AVIVA tipped for upside, but City analysts reckon its time to downgradeProactive Investors • 05/05/26
Could Aviva hand investors a 30% return in the next 12 months? This bank thinks soProactive Investors • 03/11/26
Aviva shares: why three banks think the FTSE 100 insurer is still too cheapProactive Investors • 03/09/26
Aviva hikes dividend 10% and unveils £350m buyback as 2026 targets delivered earlyProactive Investors • 03/05/26
Aviva Bio Announces FDA Guidance on Development Pathway for Women's Testosterone Therapy and New Evidence of a Reduced Risk of Breast Cancer Cell Proliferation for AVA-291Business Wire • 01/26/26
Phoenix joins Aviva and Prudential as UK life sector top picks for 2026Proactive Investors • 12/17/25